Dreman Value Management’s Meredith Corporation MDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$11K Hold
208
0.01% 388
2017
Q4
$14K Hold
208
0.01% 364
2017
Q3
$12K Hold
208
0.01% 354
2017
Q2
$12K Buy
+208
New +$12.1K 0.01% 352
2016
Q2
Sell
-205,563
Closed -$9.76M 566
2016
Q1
$9.76M Buy
+205,563
New +$8.72M 1.11% 25
2015
Q4
Sell
-205,656
Closed -$8.76M 447
2015
Q3
$8.76M Buy
205,656
+21,340
+12% +$1.02M 0.88% 37
2015
Q2
$9.61M Buy
184,316
+14,968
+9% +$793K 0.79% 37
2015
Q1
$9.45M Sell
169,348
-31,139
-16% -$1.67M 0.82% 35
2014
Q4
$10.9M Buy
200,487
+11,742
+6% +$588K 0.9% 16
2014
Q3
$8.08M Buy
188,745
+2,433
+1% +$113K 0.66% 42
2014
Q2
$9.01M Sell
186,312
-4,033
-2% -$183K 0.68% 37
2014
Q1
$8.84M Buy
190,345
+5,757
+3% +$264K 0.68% 42
2013
Q4
$9.6M Buy
184,588
+20,551
+13% +$1.05M 0.72% 23
2013
Q3
$7.81M Buy
+164,037
New +$7.61M 0.7% 28

Other funds holding MDP

Dreman Value Management's MDP Position: Q1 2018 in Review

Dreman Value Management held its Meredith Corporation (MDP) position steady in Q1 2018 at 208 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #388.

Dreman Value Management first reported a position in MDP in Q3 2013 and has held it in 14 quarters since. The position peaked at $10.9M in Q4 2014. 257 funds tracked by Wall St. Rank hold MDP as of Q1 2018.

  • Dreman Value Management held 208 shares of Meredith Corporation worth $11K as of Q1 2018.
  • Dreman Value Management left its Meredith Corporation share count unchanged in Q1 2018.
  • Meredith Corporation made up 0.01% of Dreman Value Management's portfolio in Q1 2018, its #388 holding.
  • Dreman Value Management first reported a position in Meredith Corporation in Q3 2013 and has held it in 14 quarters since.
  • Dreman Value Management's Meredith Corporation position peaked at $10.9M in Q4 2014.
  • 257 funds tracked by Wall St. Rank held Meredith Corporation as of Q1 2018.

Based on Dreman Value Management's 13F filing for Q1 2018, filed 2 May 2018.